PLAU and cervical cancer: In the present study, TSAIII was demonstrated to inhibit cell migration and invasion through the downregulation of the p38 MAPK–uPA axis in both human cervical cancer cells and cervical cancer stem cells (CCSCs) in vitro and in vivo.